Recently, scientists examined levels of GAS5 in immune-related diseases and elucidated its underlying molecular function, they concluded that the expression level of GAS5 was aberrant in patients with autoimmune disorders when compared to controls, and in addition to its tumor arresting function, GAS5 is a potent repressor of the glucocorticoid receptor (GR) (Mayama et al., 2016). This evidence concerns the gene GAS5 and neoplasm.